메뉴 건너뛰기




Volumn 4, Issue 1, 2010, Pages 809-816

Retinal vein occlusion: Pathophysiology and treatment options

Author keywords

Branch; Central; Hemispheric; Retinal vein occlusion; Visual loss

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBIN III; BEVACIZUMAB; CORTICOSTEROID; DEXAMETHASONE; HOMOCYSTEINE; INTERLEUKIN 6; LOW MOLECULAR WEIGHT HEPARIN; OZURDEX; PROTEIN C; PROTEIN S; RANIBIZUMAB; TICLOPIDINE; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; TROXERUTIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

EID: 77956113448     PISSN: 11775467     EISSN: 11775483     Source Type: Book Series    
DOI: 10.2147/opth.s7631     Document Type: Article
Times cited : (139)

References (60)
  • 1
    • 33646472759 scopus 로고    scopus 로고
    • Ten-year incidence of retinal vein occlusion in an older population: The Blue Mountains Eye Study
    • Cugati S, Wang JJ, Rochtchina E, et al. Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study. Arch Ophthalmol. 2006;124:726-732.
    • (2006) Arch Ophthalmol , vol.124 , pp. 726-732
    • Cugati, S.1    Wang, J.J.2    Rochtchina, E.3
  • 2
    • 17444394528 scopus 로고    scopus 로고
    • Prevalent misconceptions about acute retinal vascular occlusive disorders
    • Hayreh S. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retinal Eye Res. 2005;24:493-519.
    • (2005) Prog Retinal Eye Res , vol.24 , pp. 493-519
    • Hayreh, S.1
  • 3
    • 53449090577 scopus 로고    scopus 로고
    • Traditional and novel cardiovascular risk factors for retinal vein occlusion: The multiethnic study of atherosclerosis
    • Cheung N, Klein R, Wang J, et al. Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis. Invest Ophthalmol Vis Sci. 2008;49:4297-4302.
    • (2008) Invest Ophthalmol Vis Sci , vol.49 , pp. 4297-4302
    • Cheung, N.1    Klein, R.2    Wang, J.3
  • 4
    • 42249083700 scopus 로고    scopus 로고
    • The 15-year cumulative incidence of retinal vein occlusion: The Beaver Dam Eye Study
    • Klein R, Moss SE, Meuer SM, Klein BE. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol. 2008;126:513-518.
    • (2008) Arch Ophthalmol , vol.126 , pp. 513-518
    • Klein, R.1    Moss, S.E.2    Meuer, S.M.3    Klein, B.E.4
  • 5
    • 77956120588 scopus 로고    scopus 로고
    • Dexamethasone 700 μg intravitreal implant in applicator for retinal vein occlusion, 2009 Oct
    • Dexamethasone 700 μg intravitreal implant in applicator for retinal vein occlusion. Allergan advance notification document. 2009 Oct.
    • Allergan Advance Notification Document
  • 6
    • 41149136685 scopus 로고    scopus 로고
    • Dexamethasone Intravitreal Implant Approved for Retinal Vein Occlusion, Available from, Accessed on March 1, 2010
    • Dexamethasone Intravitreal Implant Approved for Retinal Vein Occlusion. Medscape Medical News. Available from: http://www.medscape.com/viewarticle/704854. Accessed on March 1, 2010.
    • Medscape Medical News
  • 7
    • 75149172639 scopus 로고    scopus 로고
    • The prevalence of retinal vein occlusion: Pooled data from population studies from the United States, Europe, Asia, and Australia
    • Rogers S, McIntosh RL, Cheung N, et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010;117:313-319.
    • (2010) Ophthalmology , vol.117 , pp. 313-319
    • Rogers, S.1    McIntosh, R.L.2    Cheung, N.3
  • 8
    • 0019768239 scopus 로고
    • Central retinal vein occlusions: A prospective histopathologic study of 29 eyes in 28 cases
    • Green WR, Chan CC, Hutchins GM, et al. Central retinal vein occlusions: A prospective histopathologic study of 29 eyes in 28 cases. Retina. 1981;1:27-55.
    • (1981) Retina , vol.1 , pp. 27-55
    • Green, W.R.1    Chan, C.C.2    Hutchins, G.M.3
  • 9
    • 3142624510 scopus 로고    scopus 로고
    • Risk factors for central retinal vein occlusion
    • The Eye Disease Case-Control Study Group
    • The Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol. 1996;114:545-554.
    • (1996) Arch Ophthalmol , vol.114 , pp. 545-554
  • 10
    • 85031640974 scopus 로고    scopus 로고
    • Risk factors for hemiretinal vein occlusion: Comparison with risk factors for central and branch retinal vein occlusion: The eye disease case-control study
    • Sperduto RD, Hiller R, Chew E, et al. Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study. Ophthalmology. 1999;106:439-440.
    • (1999) Ophthalmology , vol.106 , pp. 439-440
    • Sperduto, R.D.1    Hiller, R.2    Chew, E.3
  • 11
    • 0027319901 scopus 로고
    • Risk factors for branch retinal vein occlusion
    • The Eye Disease Case-Control Study Group
    • The Eye Disease Case-Control Study Group. Risk factors for branch retinal vein occlusion. Am J Ophthalmol. 1993;116:286-296.
    • (1993) Am J Ophthalmol , vol.116 , pp. 286-296
  • 12
    • 43549098827 scopus 로고    scopus 로고
    • Retinal vein occlusion and traditional risk factors for atherosclerosis
    • O'Mahoney P, Wong T, Ray J. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol. 2008;126:692-699.
    • (2008) Arch Ophthalmol , vol.126 , pp. 692-699
    • O'Mahoney, P.1    Wong, T.2    Ray, J.3
  • 13
    • 36248933683 scopus 로고    scopus 로고
    • Central retinal vein occlusion case-control study
    • Koizumi H, Ferrara D, Brue C, et al. Central retinal vein occlusion case-control study. Am J Ophthalmol. 2007;144:858-863.
    • (2007) Am J Ophthalmol , vol.144 , pp. 858-863
    • Koizumi, H.1    Ferrara, D.2    Brue, C.3
  • 14
    • 0036200494 scopus 로고    scopus 로고
    • Central retinal vein occlusion and thrombophilia
    • Fegan CD. Central retinal vein occlusion and thrombophilia. Eye. 2002;16:98-106.
    • (2002) Eye , vol.16 , pp. 98-106
    • Fegan, C.D.1
  • 15
    • 20444435937 scopus 로고    scopus 로고
    • Retinal vein occlusion: A form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors
    • Janssen MC, den Heijer M, Cruysberg JR, Wollersheim H, Bredie SJ. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost. 2005;93:1021-1026.
    • (2005) Thromb Haemost , vol.93 , pp. 1021-1026
    • Janssen, M.C.1    den Heijer, M.2    Cruysberg, J.R.3    Wollersheim, H.4    Bredie, S.J.5
  • 16
    • 37149027789 scopus 로고    scopus 로고
    • Assessment of risk factors for retinal vein occlusions in patients under 60 years of age
    • Salaun N, Delyfer MN, Rougier MB, Korobelnik JF. Assessment of risk factors for retinal vein occlusions in patients under 60 years of age. J Fr Ophtalmol. 2007;30:918-923.
    • (2007) J Fr Ophtalmol , vol.30 , pp. 918-923
    • Salaun, N.1    Delyfer, M.N.2    Rougier, M.B.3    Korobelnik, J.F.4
  • 17
    • 77955487469 scopus 로고    scopus 로고
    • Retinal vein occlusion: Evaluation of "classic" and "emerging" risk factors and treatment
    • Turello M, Pasca S, Daminato R, et al. Retinal vein occlusion: evaluation of "classic" and "emerging" risk factors and treatment. J Thromb Thrombolysis. 2010;29:459-464.
    • (2010) J Thromb Thrombolysis , vol.29 , pp. 459-464
    • Turello, M.1    Pasca, S.2    Daminato, R.3
  • 18
    • 33646165353 scopus 로고    scopus 로고
    • The relationship of optic disk cupping to retinal vein occlusion: The Beaver Dam Eye Study
    • Klein BE, Meuer SM, Knudtson MD, Klein R. The relationship of optic disk cupping to retinal vein occlusion: the Beaver Dam Eye Study. Am J Ophthalmol. 2006;141:859-862.
    • (2006) Am J Ophthalmol , vol.141 , pp. 859-862
    • Klein, B.E.1    Meuer, S.M.2    Knudtson, M.D.3    Klein, R.4
  • 19
    • 39449104207 scopus 로고    scopus 로고
    • Familial central retinal vein occlusion
    • Girmens JF, Scheer S, Heron E, et al. Familial central retinal vein occlusion. Eye. 2008;22:308-310.
    • (2008) Eye , vol.22 , pp. 308-310
    • Girmens, J.F.1    Scheer, S.2    Heron, E.3
  • 20
    • 0032740739 scopus 로고    scopus 로고
    • Central retinal vein occlusion: Report of two familial cases
    • Bhagat N, Goldberg MF, Gascon W, et al. Central retinal vein occlusion: report of two familial cases. Eur J Ophthalmol. 1999;9:181-195.
    • (1999) Eur J Ophthalmol , vol.9 , pp. 181-195
    • Bhagat, N.1    Goldberg, M.F.2    Gascon, W.3
  • 21
    • 41149085598 scopus 로고    scopus 로고
    • Ranibizumab for macular edema due to retinal vein occlusion: Implication of VEGF as a critical stimulator
    • Campochiaro PA, Hafiz G, Shah SM, et al. Ranibizumab for macular edema due to retinal vein occlusion: implication of VEGF as a critical stimulator. Mol Ther. 2008;16:791-799.
    • (2008) Mol Ther , vol.16 , pp. 791-799
    • Campochiaro, P.A.1    Hafiz, G.2    Shah, S.M.3
  • 22
    • 77949537099 scopus 로고    scopus 로고
    • Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases
    • Yoshimura T, Sonoda KH, Sugahara M, et al. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS ONE 2009;4(12):e8158.
    • (2009) PLoS ONE , vol.4 , Issue.12
    • Yoshimura, T.1    Sonoda, K.H.2    Sugahara, M.3
  • 23
    • 62649161064 scopus 로고    scopus 로고
    • Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab
    • Funk M, Kriechbaum K, Prager F, et al. Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab. Invest Ophthalmol Vis Sci. 2009;50: 1025-1032.
    • (2009) Invest Ophthalmol Vis Sci , vol.50 , pp. 1025-1032
    • Funk, M.1    Kriechbaum, K.2    Prager, F.3
  • 24
    • 0027942607 scopus 로고
    • Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
    • Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
    • (1994) N Engl J Med , vol.331 , pp. 1480-1487
    • Aiello, L.P.1    Avery, R.L.2    Arrigg, P.G.3
  • 25
    • 0031126380 scopus 로고    scopus 로고
    • Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates
    • Ozaki H, Hayashi H, Vinores SA, Moromizato Y, Campochiaro PA, Oshima K. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp Eye Res. 1997;64:505-517.
    • (1997) Exp Eye Res , vol.64 , pp. 505-517
    • Ozaki, H.1    Hayashi, H.2    Vinores, S.A.3    Moromizato, Y.4    Campochiaro, P.A.5    Oshima, K.6
  • 26
    • 23744502535 scopus 로고    scopus 로고
    • Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6
    • Noma H, Funatsu H, Yamasaki M, et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol. 2005;140:256-261.
    • (2005) Am J Ophthalmol , vol.140 , pp. 256-261
    • Noma, H.1    Funatsu, H.2    Yamasaki, M.3
  • 27
    • 38349179299 scopus 로고    scopus 로고
    • Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular edema in branch retinal vein occlusion
    • Noma H, Funatsu H, Yamasaki M, et al. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular edema in branch retinal vein occlusion. Eye. 2008;22:42-48.
    • (2008) Eye , vol.22 , pp. 42-48
    • Noma, H.1    Funatsu, H.2    Yamasaki, M.3
  • 28
    • 77956192669 scopus 로고    scopus 로고
    • Increase of vascular endothelial growth factor and interleukin-6 in the aqueous humour of patients with macular edema and central retinal vein occlusion
    • 2009 Jun 26
    • Noma H, Funatsu H, Mimura T, Harino S, Sone T, Hori S. Increase of vascular endothelial growth factor and interleukin-6 in the aqueous humour of patients with macular edema and central retinal vein occlusion. Acta Ophthalmol. Epub 2009 Jun 26.
    • Acta Ophthalmol
    • Noma, H.1    Funatsu, H.2    Mimura, T.3    Harino, S.4    Sone, T.5    Hori, S.6
  • 29
    • 57949103669 scopus 로고    scopus 로고
    • Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion
    • Noma H, Funatsu H, Mimura T, Harino S, Hori S. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Ophthalmology. 2009;116: 87-93.
    • (2009) Ophthalmology , vol.116 , pp. 87-93
    • Noma, H.1    Funatsu, H.2    Mimura, T.3    Harino, S.4    Hori, S.5
  • 30
    • 0036970074 scopus 로고    scopus 로고
    • Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion
    • Boyd SR, Zachary I, Chakravarthy U, et al. Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion. Arch Ophthalmol. 2002;120:1644-1650.
    • (2002) Arch Ophthalmol , vol.120 , pp. 1644-1650
    • Boyd, S.R.1    Zachary, I.2    Chakravarthy, U.3
  • 31
    • 0021221946 scopus 로고
    • Argon laser photocoagulation for macula edema in branch vein occlusion
    • The Branch Vein Occlusion Study Group
    • The Branch Vein Occlusion Study Group: Argon laser photocoagulation for macula edema in branch vein occlusion. Am J Ophthalmol. 1984;98:271-282.
    • (1984) Am J Ophthalmol , vol.98 , pp. 271-282
  • 32
    • 0022645069 scopus 로고
    • Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion
    • The Branch Vein Occlusion Study Group
    • The Branch Vein Occlusion Study Group: Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. Arch Ophthalmol. 1986;104:34-41.
    • (1986) Arch Ophthalmol , vol.104 , pp. 34-41
  • 33
    • 0028802677 scopus 로고
    • Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion
    • The Central Vein Occlusion Study Group
    • The Central Vein Occlusion Study Group: Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology. 1995;102:1425-1433.
    • (1995) Ophthalmology , vol.102 , pp. 1425-1433
  • 34
    • 0028802678 scopus 로고
    • A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion
    • The Central Vein Occlusion Study Group
    • The Central Vein Occlusion Study Group: A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. Ophthalmology. 1995;102:1434-1444.
    • (1995) Ophthalmology , vol.102 , pp. 1434-1444
  • 35
    • 77952890267 scopus 로고    scopus 로고
    • Natural history of branch retinal vein occlusion: An evidence-based systematic review
    • Rogers SL, McIntosh RL, Lim L, et al. Natural history of branch retinal vein occlusion: An evidence-based systematic review. Ophthalmology. 2010;117:1094-1101.e5.
    • (2010) Ophthalmology , vol.117 , pp. 1094-1101
    • Rogers, S.L.1    McIntosh, R.L.2    Lim, L.3
  • 36
    • 33847171921 scopus 로고    scopus 로고
    • Interventions for central retinal vein occlusion: An evidence-based systematic review
    • Mohamed Q, McIntosh RL, Saw SM, Wong TY. Interventions for central retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2007;114:507-519.
    • (2007) Ophthalmology , vol.114 , pp. 507-519
    • Mohamed, Q.1    McIntosh, R.L.2    Saw, S.M.3    Wong, T.Y.4
  • 37
    • 75749111693 scopus 로고    scopus 로고
    • Antithrombotic and fibrinolytic drugs for retinal vein occlusion: A systematic review and a call for action
    • Squizzato A, Manfredi E, Bozzato S, et al. Antithrombotic and fibrinolytic drugs for retinal vein occlusion: A systematic review and a call for action. Thromb Haemost. 2010;103:271-276.
    • (2010) Thromb Haemost , vol.103 , pp. 271-276
    • Squizzato, A.1    Manfredi, E.2    Bozzato, S.3
  • 39
    • 2942637898 scopus 로고    scopus 로고
    • Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: A report of 14 cases
    • Mandelcorn MS, Nrusimhadevara RK. Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases. Retina. 2004;24:348-355.
    • (2004) Retina , vol.24 , pp. 348-355
    • Mandelcorn, M.S.1    Nrusimhadevara, R.K.2
  • 40
    • 0034787541 scopus 로고    scopus 로고
    • Radial optic neurotomy for central retinal vein occlusion: A retrospective pilot study of 11 consecutive cases
    • Opremcak EM, Bruce RA, Lomeo MD, et al. Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases. Retina. 2001;21:408-415.
    • (2001) Retina , vol.21 , pp. 408-415
    • Opremcak, E.M.1    Bruce, R.A.2    Lomeo, M.D.3
  • 41
    • 0142164928 scopus 로고    scopus 로고
    • Radial optic neurotomy as treatment for central retinal vein occlusion
    • Weizer JS, Stinnett SS, Fekrat S. Radial optic neurotomy as treatment for central retinal vein occlusion. Am J Ophthalmol. 2003;136:814-819.
    • (2003) Am J Ophthalmol , vol.136 , pp. 814-819
    • Weizer, J.S.1    Stinnett, S.S.2    Fekrat, S.3
  • 42
    • 0031822358 scopus 로고    scopus 로고
    • Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein
    • Weiss JN. Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein. Am J Ophthalmol. 1998; 126:142-144.
    • (1998) Am J Ophthalmol , vol.126 , pp. 142-144
    • Weiss, J.N.1
  • 43
    • 23044465626 scopus 로고    scopus 로고
    • Retinal endovascular surgery for central retinal vein occlusion: Initial experience of four surgeons
    • Bynoe LA, Hutchins RK, Lazarus HS, Friedberg MA. Retinal endovascular surgery for central retinal vein occlusion: initial experience of four surgeons. Retina. 2005;25:625-632.
    • (2005) Retina , vol.25 , pp. 625-632
    • Bynoe, L.A.1    Hutchins, R.K.2    Lazarus, H.S.3    Friedberg, M.A.4
  • 44
    • 77951622350 scopus 로고    scopus 로고
    • The central retinal vein bypass study: A trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion
    • McAllister IL, Gillies M, Smithies LA, et al. The central retinal vein bypass study: A trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion. Opthalmology. 2010;117:954-965.
    • (2010) Opthalmology , vol.117 , pp. 954-965
    • McAllister, I.L.1    Gillies, M.2    Smithies, L.A.3
  • 45
    • 34247323377 scopus 로고    scopus 로고
    • Interventions for branch retinal vein occlusion: An evidence-based systematic review
    • McIntosh RL, Mohamed Q, Saw SM, Wong TY. Interventions for branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2007;114:835-854.
    • (2007) Ophthalmology , vol.114 , pp. 835-854
    • McIntosh, R.L.1    Mohamed, Q.2    Saw, S.M.3    Wong, T.Y.4
  • 46
    • 0034057988 scopus 로고    scopus 로고
    • Laser treatment and the mechanism of edema reduction in branch retinal vein occlusion
    • Arnarsson A, Stefansson E. Laser treatment and the mechanism of edema reduction in branch retinal vein occlusion. Invest Opthalmol Vis Sci. 2000;41:877-879.
    • (2000) Invest Opthalmol Vis Sci , vol.41 , pp. 877-879
    • Arnarsson, A.1    Stefansson, E.2
  • 47
    • 77951759625 scopus 로고    scopus 로고
    • Long-term study of vascular perfusion effects following arteriovenous sheathotomy for branch retinal vein occlusion
    • Muqit MM, Saidkasimova S, Keating D, Murdoch JR. Long-term study of vascular perfusion effects following arteriovenous sheathotomy for branch retinal vein occlusion. Acta Ophthalmol. 2010;88:e57-e65.
    • (2010) Acta Ophthalmol , vol.88
    • Muqit, M.M.1    Saidkasimova, S.2    Keating, D.3    Murdoch, J.R.4
  • 48
    • 0041826878 scopus 로고    scopus 로고
    • Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion
    • Park CH, Jaffe GJ, Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol. 2003;136:419-425.
    • (2003) Am J Ophthalmol , vol.136 , pp. 419-425
    • Park, C.H.1    Jaffe, G.J.2    Fekrat, S.3
  • 49
    • 3543147844 scopus 로고    scopus 로고
    • Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion
    • Ip MS, Gottlieb JL, Kahana A, et al. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol. 2004;122:1131-1136.
    • (2004) Arch Ophthalmol , vol.122 , pp. 1131-1136
    • Ip, M.S.1    Gottlieb, J.L.2    Kahana, A.3
  • 50
    • 38349169372 scopus 로고    scopus 로고
    • Intravitreal triamcinolone acetonide for macular edema owing to retinal vein occlusion
    • Patel PJ, Zaheer I, Karia N. Intravitreal triamcinolone acetonide for macular edema owing to retinal vein occlusion. Eye. 2008;22:60-64.
    • (2008) Eye , vol.22 , pp. 60-64
    • Patel, P.J.1    Zaheer, I.2    Karia, N.3
  • 51
    • 33750290838 scopus 로고    scopus 로고
    • Early effects of intravitreal triamcinolone on macular edema
    • Miyamoto N, Iossifov D, Metge F, Behar-Cohen F. Early effects of intravitreal triamcinolone on macular edema. Ophthalmology. 2006;113:2048-2053.
    • (2006) Ophthalmology , vol.113 , pp. 2048-2053
    • Miyamoto, N.1    Iossifov, D.2    Metge, F.3    Behar-Cohen, F.4
  • 52
    • 70349243148 scopus 로고    scopus 로고
    • A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: The standard care vs corticosteroid for retinal vein occlusion (SCORE) Study Report 5
    • The SCORE Study Research Group
    • The SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the standard care vs corticosteroid for retinal vein occlusion (SCORE) Study Report 5. Arch Ophthalmol. 2009;127:1101-1114.
    • (2009) Arch Ophthalmol , vol.127 , pp. 1101-1114
  • 53
    • 70349247768 scopus 로고    scopus 로고
    • A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: The standard care vs corticosteroid for retinal vein occlusion (SCORE) Study Report 6
    • The SCORE Study Research Group
    • The SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the standard care vs corticosteroid for retinal vein occlusion (SCORE) Study Report 6. Arch Ophthalmol. 2009;127:1115-1128.
    • (2009) Arch Ophthalmol , vol.127 , pp. 1115-1128
  • 54
    • 70349233834 scopus 로고    scopus 로고
    • SCOREing in retinal venous occlusive disease
    • Apte RS. SCOREing in retinal venous occlusive disease. Arch Ophthalmol. 2009;127:1203-1204.
    • (2009) Arch Ophthalmol , vol.127 , pp. 1203-1204
    • Apte, R.S.1
  • 56
    • 23044440795 scopus 로고    scopus 로고
    • Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central vein occlusion
    • Rosenfeld PJ, Fung AE, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central vein occlusion. Ophthalmic Surg Lasers Imaging. 2005;36:336-339.
    • (2005) Ophthalmic Surg Lasers Imaging , vol.36 , pp. 336-339
    • Rosenfeld, P.J.1    Fung, A.E.2    Puliafito, C.A.3
  • 57
    • 64849111444 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) for macular edema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial
    • Prager F, Michels S, Kriechbaum K, et al. Intravitreal bevacizumab (Avastin) for macular edema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Br J Ophthalmol. 2009; 93:452-456.
    • (2009) Br J Ophthalmol , vol.93 , pp. 452-456
    • Prager, F.1    Michels, S.2    Kriechbaum, K.3
  • 60
    • 34247231572 scopus 로고    scopus 로고
    • Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease
    • Matsumoto Y, Freund KB, Peiretti E, Cooney MJ, Ferrara DC, Yannuzzi LA. Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. Retina. 2007; 27:426-431.
    • (2007) Retina , vol.27 , pp. 426-431
    • Matsumoto, Y.1    Freund, K.B.2    Peiretti, E.3    Cooney, M.J.4    Ferrara, D.C.5    Yannuzzi, L.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.